Posttranslational Regulation of FOXA1 in Breast Cancer
FOXA1 在乳腺癌中的翻译后调控
基本信息
- 批准号:10978823
- 负责人:
- 金额:$ 30.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Breast cancer is the second leading cause of cancer mortality in women and nearly 75% of all breast
tumors express estrogen receptor alpha (ER) at the time of diagnosis. Despite the therapeutic successes of
endocrine therapies designed to target ER function, about 30-40% of tumors become resistant to endocrine
therapy, either through de novo or acquired resistance, and still retain the expression of ER. Herein we propose
to study the regulation of FOXA1, a pioneer transcription factor that enables ER binding to chromatin, whose
theoretical inhibition would circumvent known mechanisms of endocrine therapy resistance. In breast cancer,
FOXA1 is responsible for almost all of the ER binding events in the genome and its upregulation is associated
with enhancer reprograming in endocrine resistance. However, there is a paucity of information about how
FOXA1 itself is regulated and how cancer cells repurpose its pioneering activities to drive oncogenesis.
To this end, our lab has been studying the crosstalk between the endocrine and immune systems in
breast cancer. We have discovered that FOXA1, in response to the proinflammatory cytokines, is driven to non-
canonical sites across the genome to promote chromatin accessibility for estrogen-liganded ER. These newly
formed enhancers were found in compacted/latent regions of the genome and promoted the expression of a
novel gene set that was predictive of poor clinical outcomes in patients. Concurrently, we discovered that FOXA1
is post-translationally modified (PTM) in response to proinflammatory cytokines at two evolutionarily conserved
amino acids. The post-translational modification of FOXA1 in response to external stimuli has not been shown
before and suggests an important mechanism that underlies FOXA1 regulation and function. Therefore, the
overall goal of this project is to determine the molecular events that allow proinflammatory signaling to alter
endocrine signaling through modulation of FOXA1 function and the biological consequences of this crosstalk.
We hypothesize that estrogen- and TNFα-directed PTMs of FOXA1 dictate binding site selection, driving ERα
to non-canonical enhancers across the genome, leading to expression programs that underlie the tumorigenesis
of breast cancer. To systematically test this hypothesis, will use an integrated set of molecular, genomic, and
proteomic approaches to: (Aim 1) define the role of FOXA1 PTMs on its pioneering function and chromatin
occupancy, (Aim 2) identify the writers and readers of FOXA1 PTMs, and (Aim 3) understand inflammation-
based modulation of FOXA1 independent of PTMs. We will perform these experiments in breast cancer cell
lines, ER+ patient-derived xenografts (PDX), and in ER+ mature luminal cells isolated from patient tumors. The
dependence on FOXA1 for hormone receptor signaling makes it an attractive therapeutic target. While there are
currently no known inhibitors of FOXA1 and its protein structure makes it difficult to target therapeutically, our
ability to understand basic molecular mechanisms is directly correlated with our ability to develop better
therapeutic interventions. Defining how FOXA1 is regulated becomes key to this endeavor.
项目总结
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers.
男性乳腺癌的单细胞转录和表观遗传学特征提名了明显的癌症特异性增强子。
- DOI:10.3390/ijms241713053
- 发表时间:2023-08-22
- 期刊:
- 影响因子:5.6
- 作者:Kim, Hyunsoo;Wisniewska, Kamila;Regner, Matthew J.;Thennavan, Aatish;Spanheimer, Philip M.;Franco, Hector L.
- 通讯作者:Franco, Hector L.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hector Luis Franco其他文献
Hector Luis Franco的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hector Luis Franco', 18)}}的其他基金
Posttranslational Regulation of FOXA1 in Breast Cancer
FOXA1 在乳腺癌中的翻译后调控
- 批准号:
10504308 - 财政年份:2022
- 资助金额:
$ 30.6万 - 项目类别:
Posttranslational Regulation of FOXA1 in Breast Cancer
FOXA1 在乳腺癌中的翻译后调控
- 批准号:
10671553 - 财政年份:2022
- 资助金额:
$ 30.6万 - 项目类别:
Mechanisms of FoxA1 Latent Enhancer Formation in Response to Proinflammatory Signaling in Hormone Dependent Cancers
FoxA1 潜在增强子形成响应激素依赖性癌症促炎信号的机制
- 批准号:
9405057 - 财政年份:2017
- 资助金额:
$ 30.6万 - 项目类别:
Project 2: Inflammation-Based Mechanisms of Hormone Therapy Resistance in Breast Cancer
项目2:基于炎症的乳腺癌激素治疗耐药机制
- 批准号:
10011766 - 财政年份:1997
- 资助金额:
$ 30.6万 - 项目类别:
Project 2: Inflammation-Based Mechanisms of Hormone Therapy Resistance in Breast Cancer
项目2:基于炎症的乳腺癌激素治疗耐药机制
- 批准号:
10468785 - 财政年份:1997
- 资助金额:
$ 30.6万 - 项目类别:
Project 2: Inflammation-Based Mechanisms of Hormone Therapy Resistance in Breast Cancer
项目2:基于炎症的乳腺癌激素治疗耐药机制
- 批准号:
10244930 - 财政年份:1997
- 资助金额:
$ 30.6万 - 项目类别:
Project 2: Inflammation-Based Mechanisms of Hormone Therapy Resistance in Breast Cancer
项目2:基于炎症的乳腺癌激素治疗耐药机制
- 批准号:
9768359 - 财政年份:
- 资助金额:
$ 30.6万 - 项目类别:
相似海外基金
BRIDGEGAP - Bridging the Gaps in Evidence, Regulation and Impact of Anticorruption Policies
BRIDGEGAP - 缩小反腐败政策的证据、监管和影响方面的差距
- 批准号:
10110711 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
EU-Funded
p53PRISM: Regulation of life-and-death decisions by conformational switches
p53PRISM:构象开关调节生死决定
- 批准号:
EP/Z000823/1 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Fellowship
Conference: 2024 Thiol-Based Redox Regulation and Signaling GRC and GRS: Mechanisms and Consequences of Redox Signaling
会议:2024年基于硫醇的氧化还原调节和信号传导GRC和GRS:氧化还原信号传导的机制和后果
- 批准号:
2418618 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Standard Grant
Investigating the potential for developing self-regulation in foreign language learners through the use of computer-based large language models and machine learning
通过使用基于计算机的大语言模型和机器学习来调查外语学习者自我调节的潜力
- 批准号:
24K04111 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Conference: 2024 Post-Transcriptional Gene Regulation Gordon Research Conference and Seminar: The Versatility of RNA in the Living World
会议:2024年转录后基因调控戈登研究会议及研讨会:RNA在生活世界中的多功能性
- 批准号:
2422760 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Standard Grant
NSF PRFB FY23: Cross-species gene regulation of a plant-fungal symbiosis under environmental stress
NSF PRFB FY23:环境胁迫下植物-真菌共生的跨物种基因调控
- 批准号:
2305481 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Fellowship Award
CAREER: Uncovering the role of splicing factors in transcriptional regulation
职业:揭示剪接因子在转录调控中的作用
- 批准号:
2339464 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Continuing Grant
CAREER: Elucidating spatial and epigenetic regulation of gene expression during human development using photopatterning and single-cell multiomics
职业:利用光模式和单细胞多组学阐明人类发育过程中基因表达的空间和表观遗传调控
- 批准号:
2339849 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Continuing Grant
Role of chromatin remodeling in gene regulation during maize basal endosperm development
染色质重塑在玉米基础胚乳发育过程中基因调控中的作用
- 批准号:
2341575 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Continuing Grant
BRC-BIO: Epigenetic Regulation of Transposable Elements in Maize
BRC-BIO:玉米转座元件的表观遗传调控
- 批准号:
2334573 - 财政年份:2024
- 资助金额:
$ 30.6万 - 项目类别:
Standard Grant